New Study Finds Repeat Opioid Overdose Risk Far Higher Than Previously Estimated
A new study is raising concerns about the dangers facing people who survive an opioid overdose, revealing that repeat overdoses occur much more frequently than earlier research suggested.
Researchers found that individuals treated in emergency departments following an opioid overdose face a substantial risk of experiencing another overdose within the following year. The findings highlight the ongoing challenges of the opioid crisis and underscore the urgent need for expanded access to treatment, recovery services and overdose prevention resources.
Repeat Overdoses More Common Than Expected
For years, experts estimated that approximately 6% of opioid overdose survivors would experience another overdose within one year. However, new research published in the Journal of the American Medical Association (JAMA) suggests the actual risk may be significantly higher.
According to the study, roughly 21% of individuals who survived an opioid overdose and received emergency medical treatment experienced at least one additional overdose within the following 12 months.
The findings indicate that surviving an overdose should be viewed as a critical intervention point rather than the end of the medical emergency.
Researchers also found that the likelihood of death increased as individuals experienced additional overdose events, emphasizing the cumulative dangers associated with ongoing opioid use and repeated exposure to the increasingly toxic illicit drug supply.
The Impact of FYL on Overdose Trends
One major factor contributing to the increase in repeat overdoses is the widespread presence of FYL and other powerful synthetic opioids in the unregulated drug market.
Lead researcher Dr. Robert Kleinman, Assistant Professor of Psychiatry at the University of Toronto, noted that many earlier studies were conducted before FYL became dominant in illicit drug supplies.
"Most previous research was completed before FYL became widespread in the drug market," Kleinman explained. "Today's drug supply is significantly more toxic and carries a much higher risk of overdose and death."
Because FYL is substantially more potent than many traditional opioids, even small variations in dosage can produce life-threatening consequences. In many regions, individuals may unknowingly consume FYL-contaminated substances, increasing the risk of both initial and repeat overdoses.
Study Examined Thousands of Overdose Survivors
To better understand current overdose outcomes, researchers analyzed health records from nearly 28,500 individuals who were treated for opioid overdoses in emergency departments throughout Ontario, Canada between 2017 and 2023.
The study tracked patients after their initial overdose treatment to evaluate rates of repeat overdose and mortality.
The results revealed alarming patterns:
- Within 30 days of the overdose event, approximately 2% of patients had died.
- During that same first month, 6% experienced another overdose.
- Within one year, approximately 9% had died.
- Twenty-one percent suffered a repeat overdose during the following year.
These findings suggest that the period immediately following an overdose is one of extreme vulnerability and represents a crucial opportunity for intervention.
Emergency Departments Play a Critical Role
Researchers believe emergency departments are uniquely positioned to connect overdose survivors with life-saving treatment and support services.
Dr. Kleinman emphasized the importance of making evidence-based interventions readily available before patients leave the hospital.
"The elevated risks following discharge highlight the need to ensure that treatments such as opioid agonist therapy and take-home Naloxone are accessible to individuals who survive an overdose," he said.
Opioid agonist treatments, including medications such as methadone and buprenorphine, have been shown to reduce cravings, decrease illicit opioid use and lower overdose risk. Likewise, widespread access to Naloxone remains one of the most effective tools for preventing fatal overdoses.
Actual Risks May Be Even Higher
Researchers caution that the study's findings may underestimate the true scope of the problem.
The analysis only captured overdoses that resulted in emergency department visits. Overdoses that were reversed with Naloxone in the community, managed without hospital care or otherwise unreported were not included in the data.
As a result, the actual rate of repeat overdose may be substantially higher than reported.
The researchers say additional studies are needed to better understand the full burden of repeat overdoses and identify the most effective strategies for reducing mortality among people with opioid use disorder.
Building Better Care Pathways
Senior study author Dr. Paul Kurdyak, Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES), said the findings highlight the need for more comprehensive and consistent treatment approaches for patients who present to emergency departments with opioid-related emergencies.
"The mortality rates observed in this study are deeply concerning," Kurdyak said. "Developing evidence-based care pathways for people who arrive at emergency departments following an overdose or experiencing withdrawal could help reduce deaths and improve access to treatment."
Such care pathways may include:
- Immediate referral to addiction treatment services
- Rapid initiation of methadone or buprenorphine therapy
- Distribution of take-home Naloxone kits
- Peer support and recovery coaching
- Follow-up outreach after discharge
- Connections to housing, mental health and social support services
Experts increasingly view overdose survival as a critical opportunity to engage individuals in care and reduce the likelihood of future harm.
Looking Ahead
While overdose deaths have declined in some regions, the continued presence of FYL and other synthetic opioids means that people who survive an overdose remain at exceptionally high risk.
The new findings serve as a reminder that overdose prevention extends beyond emergency treatment. Long-term recovery support, medication-assisted treatment, harm reduction services and access to Naloxone all play essential roles in preventing repeat overdoses and saving lives.
As communities continue responding to the opioid crisis, ensuring that overdose survivors receive immediate access to evidence-based care may be one of the most effective strategies for reducing future overdose deaths and helping individuals begin their recovery journey.
Source: US News